Recommended treatment for hepatitis C virus genotype 1 (HCV-1) patients is peginterferon plus ribavirin for 48 weeks. We assessed whether treatment duration of 24 weeks is as effective as standard treatment in HCV-1 patients with a rapid virological response (RVR; seronegative for hepatitis C virus
Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C
โ Scribed by F. F. POORDAD
- Book ID
- 108605922
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 543 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6
contraindicate the use of drugs such as hydroxymethyl-glutaryl-coenzyme A inhibitors (statins). Statins, as the most popular cholesterollowering agents, are widely used in the MS and display in vitro anti-HCV properties. 6 However, results from an in vivo pilot study with atorvastatin have been disa
In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated